'Most Compelling' Data Yet for Metastasis-Directed Therapy in Prostate Cancer

(MedPage Today) — Metastasis-directed therapy (MDT) with radiation or surgery for men with oligometastatic prostate cancer was associated with improved outcomes in a systematic review and meta-analysis.
Across six randomized trials in a trial…

Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/119742

Author :

Publish date : 2026-02-04 21:52:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

‘Most Compelling’ Data Yet for Metastasis-Directed Therapy in Prostate Cancer

FDA Wants Drug Pulled From Market, Citing Liver Risk. Company Says No

More Evidence That Removing Fallopian Tubes Dramatically Reduces Ovarian Cancer Risk

Related Posts

Period blood test could be alternative to cervical screening, study says

Autism Prevalence in Girls and Boys May Be Nearly Equal, Study Suggests

‘Time Is Brain’ Again, Now for Hemostatic Control of Intracerebral Bleeds

Dems Hijack CMS Fraud Hearing, Cast Spotlight on ‘Federal Terror’ Campaign

Heart Attack, Stroke Risk Rises After Serious RSV, Study Says

More Evidence That Removing Fallopian Tubes Dramatically Reduces Ovarian Cancer Risk

Period blood test could be alternative to cervical screening, study says

Autism Prevalence in Girls and Boys May Be Nearly Equal, Study Suggests

‘Time Is Brain’ Again, Now for Hemostatic Control of Intracerebral Bleeds

Dems Hijack CMS Fraud Hearing, Cast Spotlight on ‘Federal Terror’ Campaign

Heart Attack, Stroke Risk Rises After Serious RSV, Study Says

More Evidence That Removing Fallopian Tubes Dramatically Reduces Ovarian Cancer Risk

‘Most Compelling’ Data Yet for Metastasis-Directed Therapy in Prostate Cancer

FDA Wants Drug Pulled From Market, Citing Liver Risk. Company Says No

Categories

Archives